Krystal Biotech, Inc. (KRYS)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Krystal Biotech, Inc. (KRYS)
Go deeper and ask any question about KRYS
Company Performance
Current Price
as of Sep 18, 2024$182.74
P/E Ratio
50.02
Market Cap
$5.25B
Description
Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Metrics
Overview
- HQPittsburgh, PA
- SectorHealth Technology
- IndustryBiotechnology
- TickerKRYS
- Price$182.74-3.44%
Trading Information
- Market Cap$5.25B
- Float84.17%
- Average Daily Volume (1m)224,421
- Average Daily Volume (3m)355,176
- EPS$3.77
Company
- Revenue$166.23M
- Rev Growth (1yr)N/A
- Net Income$15.57M
- Gross Margin88.62%
- EBITDA Margin32.80%
- EBITDA$23.05M
- EV$4.89B
- EV/Revenue29.42
- P/E50.02
- P/S32.58
Documents
SEC Filings
Factset Street Account